Next Century Growth Investors’s Insys Therapeutics, Inc. INSY Stock Holding History

Next Century Growth Investors’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-777,668	Closed	-$22.3M	–	186
2015 Q4	$22.3M	Sell	777,668 -10,866	-1%	-$301K	0.96%	35
2015 Q3	$22.4M	Buy	788,534 +258,791	+49%	+$9.52M	0.93%	36
2015 Q2	$19M	Sell	529,743 -17,445	-3%	-$543K	0.66%	47
2015 Q1	$15.9M	Buy	+547,188	New	+$14.5M	0.56%	60

Other funds holding INSY

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Next Century Growth Investors's INSY Position: Q1 2016 in Review

Next Century Growth Investors sold out of Insys Therapeutics, Inc. (INSY) in Q1 2016, closing a stake of 777,668 shares — an estimated $22.3M sold.

Next Century Growth Investors first reported a position in INSY in Q1 2015 and held it in 4 quarters. The position peaked at $22.4M in Q3 2015. 138 funds tracked by Wall St. Rank hold INSY as of Q1 2016.

Next Century Growth Investors reported no remaining Insys Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
Next Century Growth Investors sold 777,668 Insys Therapeutics, Inc. shares in Q1 2016, an estimated $22.3M.
Next Century Growth Investors first reported a position in Insys Therapeutics, Inc. in Q1 2015 and held it in 4 quarters.
Next Century Growth Investors's Insys Therapeutics, Inc. position peaked at $22.4M in Q3 2015.
138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2016.

Based on Next Century Growth Investors's 13F filing for Q1 2016, filed 13 May 2016.